Author

Robin Osterhout 1

1 Gossamer Bio, Inc.,San Diego,United States

ASSESSMENT OF COMPOSITE ENDPOINTS COMPRISING SYMPTOMATIC, HISTOLOGIC, ENDOSCOPIC, AND MOLECULAR IMPROVEMENT IN A PHASE 1B STUDY OF GB004, A GUT-TARGETED, HYPOXIA-INDUCIBLE FACTOR (HIF)-1Α STABILIZER, IN MILD-TO-MODERATE ULCERATIVE COLITIS

Kartik Raghupathi, Robin Osterhout, Brian Feagan, William J. Sandborn, Courtney Van Biene, Allan Olson, Richard Aranda, Barrett G. Levesque, Silvio Danese

Item 1 - 1 / 1
1